Fabio
5.3 KiB
5.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmaceutical Substance Manufacturing Grant Fund; created. | Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076. | us/states/va | Virginia General Assembly | 2026 | SB 527 | Virginia SB 527 (2026) |
|
enacted |
|
2 | 29 | 7 | 2026-01-13 | 2026-04-13 | openstates | ocd-bill/c63c0e97-1fbb-41f4-97ed-249c9c1d2463 | https://lis.virginia.gov/bill-details/20261/SB527 | b582fb3c7da6cb68fd809a4f4538ea57e23194c070858670aa82f24ea2ef7ef9 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 527 (2026) — Pharmaceutical Substance Manufacturing Grant Fund; created.
Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Reported from Appropriations — 22–0 (pass) · lower
- Reported from Finance and Appropriations — 14–0 (pass) · upper
- Constitutional reading dispensed R — 40–0 (pass) · upper
- Rereferred from Commerce and Labor — 11–0 (pass) · upper
- Passage R — 39–0 (pass) · upper
- Rereferred from Education and Health — 14–0 (pass) · upper
- H VOTE: — 92–6 (pass) · lower
Sponsors
- R. Creigh Deeds — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-13 Prefiled and ordered printed; Offered 01-14-2026 26102905D
filing, introduction - 2026-01-13 Referred to Committee on Education and Health
referral-committee - 2026-01-22 Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)
referral-committee - 2026-01-23 Fiscal Impact Statement from Department of Planning and Budget (SB527)
- 2026-02-02 Rereferred from Commerce and Labor to Finance and Appropriations (11-Y 0-N)
referral-committee - 2026-02-10 Reported from Finance and Appropriations (14-Y 0-N)
committee-passage - 2026-02-11 Rules suspended
- 2026-02-11 Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 2026-02-11 Passed by for the day Block Vote (Voice Vote)
- 2026-02-12 Read second time
reading-2 - 2026-02-12 Engrossed by Senate (Voice Vote)
- 2026-02-13 Read third time and passed Senate (39-Y 0-N 0-A)
passage, reading-3 - 2026-02-19 Placed on Calendar
- 2026-02-19 Read first time
reading-1 - 2026-02-19 Referred to Committee on Appropriations
referral-committee - 2026-02-19 Assigned HAPP sub: Commerce Agriculture & Natural Resources
referral-committee - 2026-02-25 Reported from Appropriations (22-Y 0-N)
committee-passage - 2026-02-27 Read second time
reading-2 - 2026-03-02 Moved from Uncontested Calendar to Regular Calendar
- 2026-03-02 Read third time
reading-3 - 2026-03-02 Passed House (92-Y 6-N 0-A)
passage - 2026-03-05 Enrolled
enrolled - 2026-03-05 Bill text as passed Senate and House (SB527ER)
passage - 2026-03-05 Fiscal Impact Statement from Department of Planning and Budget (SB527)
- 2026-03-05 Signed by Speaker
passage - 2026-03-05 Signed by President
passage - 2026-03-10 Enrolled Bill communicated to Governor on March 10, 2026
enrolled, executive-receipt - 2026-03-10 Governor's Action Deadline 11:59 p.m., April 13, 2026
executive-receipt - 2026-04-13 Approved by Governor-Chapter 809 (effective 7/1/2026)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/c63c0e97-1fbb-41f4-97ed-249c9c1d2463. Confidence: reported (aggregated from official Virginia legislature records).